Sanofi Cambodia has launched its three-year Cambodia Education Program on Diabetes (CEP-D) at Phnom Penh Hotel on the 11th of August 2018 as part of its mission to tackle the tough challenge of diabetes in the Kingdom. CEP-D’s launching marked the start of a significant move for Sanofi Cambodia to effectively promote better care and management of diabetes. “The objective of this campaign is to raise public awareness of the disease and its very serious public health impacts. Moreover, we will also try to equip the medical community in Cambodia with the latest medical science information and knowledge” said Ms Dao Thu Nga, head of Sanofi Cambodia Operations.
H.E Thir Kruy, Secretary of State and president of Medical Council of Cambodia, said that the programme will gather all the healthcare professionals across the country and open a well-founded platform for doctors and specialists to share their knowledge and experiences.
Cambodia’s recorded rate of diabetes is lower than its Southeast Asian neighbours, but the prevalence of the disease among those aged between 20 and 30 is higher in Cambodia than it is in the Western Pacific region and the rest of the world, according to the International Diabetes Federation – Western Pacific. Based on a survey by the Ministry of Health in 2010, 2.3 percent of the population in rural areas and 5.6 percent in urban areas have diabetes.
The International Diabetes Federation revealed that there are 230,800 cases of diabetes in Cambodia in 2015. “But the number today is likely to be a lot higher,” said Professor Dr Koy Vanny, president of Cambodia Society of Diabetology and Endocrinology.
CEP-D, with a budget of nearly $500,000, will involve curriculum development, training of approximately 1,180 healthcare professionals and reinforcement of students’ awareness on diabetes. The programme will also elevate existing peer-to-peer support groups of diabetic patients and create new ones, conduct educational activities and run blood test events. These efforts will be backed up by solid media campaigns and a countryside roadshow.
Sanofi Cambodia will also lead the formation of an advocacy body along with the Cambodia Society of Diabetology and Endocrinology (CSDE), Ministry of Health (MoH), University of Health Sciences (UHS) and other related organisations.
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Consumer Healthcare. Sanofi has been helping patients in Cambodia since 1992, via the Roussel Uclaf Office of representation which became the Société Rousse Cambodge in 1993.
Focused on the patients’ needs, Sanofi Cambodia is committed to improve access to medicines and healthcare, to make a difference in 16 million Cambodian people’s daily lives.